Polar Capital Holdings Plc Boosts Stock Holdings in Astera Labs, Inc. $ALAB

Polar Capital Holdings Plc increased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 120.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 684,453 shares of the company’s stock after purchasing an additional 373,836 shares during the period. Polar Capital Holdings Plc’s holdings in Astera Labs were worth $113,866,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Lido Advisors LLC boosted its stake in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the last quarter. Perigon Wealth Management LLC boosted its position in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares during the last quarter. Clearstead Advisors LLC boosted its position in shares of Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after buying an additional 76 shares during the last quarter. Sound Income Strategies LLC increased its holdings in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its holdings in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on ALAB shares. Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Roth Mkm reissued a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Stifel Nicolaus raised their target price on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Morgan Stanley boosted their target price on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $361.71 on Wednesday. The stock’s 50-day simple moving average is $247.50 and its two-hundred day simple moving average is $182.34. The stock has a market capitalization of $62.00 billion, a price-to-earnings ratio of 244.40, a PEG ratio of 5.15 and a beta of 3.94. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $398.13.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the firm posted $0.33 EPS. Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 2,161,256 shares of company stock valued at $459,844,296. 10.40% of the stock is currently owned by company insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.